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Abstract
Background: Enterotoxigenic Escherichia coli (ETEC) substantially contributes to the burden of diarrheal illnesses in
developing countries. With the use of complementary in vitro models of the human digestive environment, TNO
gastrointestinal model (TIM-1), and Mucosal Simulator of the Human Intestinal Microbial Ecosystem (M-SHIME), we
provided the first detailed report on the spatial-temporal modulation of ETEC H10407 survival, virulence, and its
interplay with gut microbiota. These systems integrate the main physicochemical parameters of the human upper
digestion (TIM-1) and simulate the ileum vs ascending colon microbial communities and luminal vs mucosal
microenvironments, captured from six fecal donors (M-SHIME).
Results: A loss of ETEC viability was noticed upon gastric digestion, while a growth renewal was found at the end
of jejunal and ileal digestion. The remarkable ETEC mucosal attachment helped to maintain luminal concentrations
above 6 log10 mL
−1 in the ileum and ascending colon up to 5 days post-infection. Seven ETEC virulence genes
were monitored. Most of them were switched on in the stomach and switched off in the TIM-1 ileal effluents and
in a late post-infectious stage in the M-SHIME ascending colon. No heat-labile enterotoxin production was
measured in the stomach in contrast to the ileum and ascending colon. Using 16S rRNA gene-based amplicon
sequencing, ETEC infection modulated the microbial community structure of the ileum mucus and ascending colon
lumen.
Conclusions: This study provides a better understanding of the interplay between ETEC and gastrointestinal cues
and may serve to complete knowledge on ETEC pathogenesis and inspire novel prophylactic strategies for diarrheal
diseases.
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Background
The food and waterborne enterotoxigenic Escherichia
coli (ETEC) is one of the major etiological agents of trav-
eler’s diarrhea and infant diarrhea in the world [1].
Strongly associated with poor hygiene facilities, ETEC
has chiefly affected low-income civilizations in south
Asia, Africa, and Latin America. An estimated 44 million
of ETEC-related diarrheal diseases occur annually,
resulting in 113,000 deaths in 2015 [2, 3].
Once ingested at a dose of 108 to 1010 cells in adults
[4], ETEC pursues a sophisticated strategy to withstand
the stringent factors encountered in successive gastro-
intestinal niches (e.g., acidic pH, bile acids, antimicrobial
peptides, and gut microbes) [1]. In the distal part of the
small intestine, ETEC effectively penetrates the mucus
layer through mucin-degrading proteins, promoting
ETEC attachment to the intestinal epithelial cells [5].
Such adhesion is orchestrated by a primary set of fim-
brial (e.g., CFA, FimH), non-fimbrial (e.g., Tia) adhesins,
and accessory colonization factors like EtpA. The adhe-
sion will facilitate the production and delivery of heat-
labile (LT) and/or heat-stable (ST) enterotoxins, the
hallmark of ETEC pathogenesis [6]. LT excretion in the
intestinal lumen is mediated by the protein labile entero-
toxin output (LeoA) and type-2 secretion system, while
ST excretion is mediated through the TolC channel [6,
7]. Upon release and binding in the small intestine, LT
and/or ST enzymatic activity results in the opening of
cystic fibrosis transmembrane regulator which creates an
osmotic movement of water into the intestinal lumen,
leading to profuse watery diarrhea.
So far, the underlying mechanisms of ETEC pathogen-
esis through its survival and virulence in the human
gastrointestinal tract remain scarcely understood. Al-
though ethically constrained, the use of wild and attenu-
ated ETEC in human challenges is suitable in order to
follow the onset of symptoms [8]. However, to assess
ETEC behavior throughout the human gut, these trials
are ethically and practically not appropriated since they
require a dynamic sampling of the gastrointestinal con-
tent. As a means of recourse, ETEC findings predomin-
antly originate from animal models, intestinal epithelial
cell cultures, and simple static in vitro models of the hu-
man gastrointestinal tract. All these approaches are re-
spectively limited by clear differences between animal
and human gut physiology, the ignorance of successive
gastrointestinal niches encountered by the pathogen
prior to host/cell interactions, and the simplicity of
in vitro models simulating only one digestive parameter
at a time. In addition, only three recent studies have ex-
plored the human gut microbiota changes during the
initiation and progression of ETEC diarrhea [9–11]. No
data are available on how the human gut microbiota
may influence ETEC survival and virulence. The few
studies available all relied on fecal samples and rectal
swabs collected from patients that experienced an ETEC
episode, or in the course of a clinical trial where healthy
adults have been challenged with an infra-physiological
dose of ETEC [9–11]. However, it is generally accepted
that fecal microbial communities fundamentally differ
from microbial communities residing in other locations
in the gastrointestinal tract.
Therefore, integration and sequential delivery of
gastrointestinal signals are needed to model the dynam-
ics and complexity of the human gut more closely as
well as to investigate ETEC behavior in different gastro-
intestinal environments. In particular, simulation of the
gastric pH drop, representative gastrointestinal transit
time, and reproduction of a highly complex gut micro-
biota from human origin are some of the key parameters
required to strengthen the conclusion of previous stud-
ies. Regionalized and dynamic in vitro models are valu-
able alternatives to fully assess pathogenic strains and
more closely approximate the complexity of the human
gastrointestinal physiology. Among the available systems,
the multi-compartmental and computer-controlled TNO
gastrointestinal model (TIM-1) is currently considered
as the most complete simulator of the upper gastrointes-
tinal tract by simulating the main physicochemical pa-
rameters of the human digestion [12, 13] (Fig. 1a).
Similarly, the Mucosal Simulator of the Human Intes-
tinal Microbial Ecosystem (M-SHIME) is the most
complete multistage system of the lower gastrointestinal
tract, cultivating a complex gut microbiota under con-
trolled environmental conditions and mimicking the
main abiotic factors of colonic fermentation process [14]
(Fig. 1b). Those in vitro systems have been well-
validated by in vitro/in vivo correlation studies [15–17].
In the present study, we operated the complementary
in vitro gut models TIM-1 and M-SHIME in order to
unravel the mechanisms associated with ETEC H10407
pathogenesis in the human gastrointestinal tract and to
monitor the regionalized gut microbial succession fol-
lowing ETEC infection. Hence, this study greatly con-
tributes to assessing the dynamics of ETEC survival,
physiological state, and its virulence features, in succes-
sive gut niches that the pathogen encounters in humans.
So far, our work represents the most complete survey of
ETEC pathogenesis in the mimicked human gastrointes-
tinal ecosystem.
Results
Gastric acid prevents ETEC survival while small intestinal
conditions help promoting its growth renewal at the end
of gastrointestinal digestion
The TIM-1 was used to simulate the effect of physico-
chemical parameters and upper gastrointestinal transit
on ETEC survival (Fig. 2a). At time point T0, a glass of
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Fig. 1 TIM-1 and M-SHIME set-up of the present study. a On the left side, picture of the TIM-1 system mimicking the main physicochemical
parameters of the gastro-intestinal digestion (gastric pH, digestive secretion delivery, transit time, and passive absorption). Experiments were
reproducing an adult ingesting a glass of water contaminated with ETEC. On the right side, sampling times (minutes) associated to the gut
regions. Samples were taken directly in each compartment; or indirectly by pooling the gastric effluents when the stomach compartment was
solely used, or the ileal effluents when the entire system was used. b Picture of the M-SHIME system mimicking the digestive and fermentative
conditions of three individuals. The run has been performed twice (six distinct individuals). The stomach/combined duodenum-jejunum vessel
was connected with three ileum bioreactors coupled to three ascending colon vessels. Upon start-up (day 0), the ascending colons were
inoculated with the fecal samples obtained from three individuals. The fecal inoculation of the ileum started at day 3, by introducing a small
amount of the fecal suspension collected in the ascending colon for each individual. To reproduce the mucosal phase, microcosms coated with
type III mucin-agar were introduced in each ileum and ascending colon vessels. ETEC infection was performed at day 13 in the ileum. Samples
were taken daily during the 20 days fermentation
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ETEC-contaminated water (7.7 ± 0.1 log10 mL
−1) was in-
troduced into the stomach compartment. During
in vitro digestion, regionalized kinetics of ETEC survival
were compared to a non-absorbable inert transit marker,
representing a 100% survival (Fig. 2a). In the gastric
compartment, a loss of ETEC viability was observed
from 45min digestion and associated to a rapid real-
time pH drop. ETEC remained at 2.9 ± 0.9 log10 mL
−1 at
the end of gastric digestion (T60 min). In the duodenum,
ETEC concentrations gradually decreased until 120 min
digestion and tended to recover from 180min. Con-
versely, in the jejunum and ileum, ETEC kinetics paral-
leled that of the transit marker during the first 180 min
of digestion. A slight re-growth was afterwards observed
in both gut regions. ETEC reached 6.6 ± 0.6 log10 mL
−1
and 7.3 ± 0.3 log10 mL
−1 at the end of the jejunal (T300
min) and ileal (T240min) digestion, respectively (Fig. 2a).
At the end of the upper gastrointestinal digestion, a global
ETEC survival percentage of 65 ± 31% was found in
pooled gastrointestinal effluents (Additional file 1: Fig. S1).
Mucosal niches harbor ETEC’s colonization in ileum and
ascending colon
The impact of the ileal and ascending colon environ-
ments on ETEC colonization was assessed in the M-
SHIME (Fig. 2b). To account for inter-individual vari-
ability in gut microbiota composition and metabolic ac-
tivity, microbial communities deriving from six healthy
human individuals were tested. On top of the luminal
microenvironments, the intestinal mucus layer was
reproduced in both ileum and ascending colon compart-
ments. Given the complex microbial background, the
gspD gene was used to characterize dynamics of ETEC
survival in the M-SHIME. ETEC suspensions obtained
after static gastro-jejunal digestion were inoculated in
the SHIME ileum (8.8 ± 0.3 log10 mL
−1 gspD copy num-
ber) (Fig. 2b). ETEC concentrations were significantly
higher in luminal vs mucosal phases in ileum and as-
cending colon 1 h (p = 0.03), respectively, 5 h post-
infection (p = 0.03), as determined by pairwise Wilcoxon
rank sum tests with Holm correction. In contrast, at a
later stage in the ileum (96 h post-infection), ETEC gspD
copy numbers were significantly higher in mucosal vs lu-
minal phase with 7.3 ± 1.0 log10 mL
−1 compared to 6.8 ±
0.9 log10 mL
−1 (p = 0.03). In the ascending colon (98 h
post-infection), luminal and mucosal niches did not dis-
play a significant difference of ETEC gspD copy numbers
and remained above 7 log10 mL
−1 (p = 0.18). Overall, the
remarkable ETEC mucosal attachment helped to main-
tain luminal concentrations above 6 log10 mL
−1 until the
end of the follow-up period, which was 120 h, respect-
ively, 122 h post-infection in the ileum and ascending
colon (Fig. 2b).
ETEC modulates its membrane physiology according to
the gastrointestinal niches
To further investigate the effect of gastrointestinal diges-
tion on ETEC pathogenesis, the physiology of ETEC
membranes was monitored in the TIM-1 by propidium
monoazide (PMA)-qPCR (Fig. 3a) and Live/Dead flow cy-
tometry (Additional file 1: Fig. S2). Two subpopulations
were discriminated by PMA-qPCR (Fig. 3a) while four
ETEC membrane states were distinguished with flow cy-
tometry by gating on the cytogram (Additional file 1: Fig.
S2A). At the initial time T0, 64% of the population was de-
tected as viable (Fig. 3a). During gastric digestion, the
ETEC fraction with intact membranes decreased over
time, indicating that most of the cells reaching the small
intestine were damaged (Fig. 3a, Additional file 1: Fig.
S2B). This result was in accordance with a notably low
ETEC intracellular pH (pHi) in the gastric compartment
(Additional file 1: Table S1) and a membrane
depolarization at 60min in the gastric effluents (Add-
itional file 1: Table S2). In the ileal effluents, reflecting all
environments crossed by ETEC along the gastric then in-
testinal digestion, flow cytometry analysis displayed a res-
toration of ETEC membrane physiology and the return to
a slight alkaline pHi as well as a membrane polarization
(Additional file 1: Fig. S2B, Tables S1–2). ETEC mem-
brane restoration was less evident with PMA-qPCR ana-
lysis since the 78% displayed at 300min represents a mix
of both dead and damaged cells (Fig. 3a). Consequently, at
the end of the gastrointestinal digestion, nearly 1/4 of the
total ETEC cells entering the colon had an intact mem-
brane (Fig. 3a, Additional file 1: Fig. S2B).
In the M-SHIME, the use of flow cytometry was im-
possible due to the complex microbial background.
PMA-qPCR was the sole technique employed to track
ETEC viability in the luminal phase (Fig. 3b). Three
hours post-infection in the ileum and 5 h post-infection
in ascending colon, the number of viable ETEC tended
to increase in comparison with pre-digested ETEC in-
oculum containing approximately 24% living cells (p =
0.03), as determined by pairwise Wilcoxon rank sum
tests with Holm correction. The ratio of intact ETEC
cells progressively decreased along fermentation with an
important donor variability in the ileum. In the ascend-
ing colon, all donors displayed a low number (13%) of
viable ETEC 29 h post-infection (Fig. 3b).
ETEC virulence gene expression profiles are affected by
gastrointestinal passage in the TIM-1 and niche-specific
gut environments in the M-SHIME
The expression of the main ETEC H10407 virulence genes
encoding for attachment and colonization (cfa/Ib, tia,
fimH), enterotoxin production (eltB, estP), and release of
enterotoxins (leoA, tolC) within the host was followed up
over time in the TIM-1 and luminal phase of the SHIME.
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The log2 fold change of each gene at any time point was
thereto compared with ETEC T0 (in a glass of water prior
to gastric digestion in TIM-1 vs ETEC T0 after pre-
gastro-jejunal digestion in batch prior to introduction in
M-SHIME ileum), and results are shown for each replicate
individually (Fig. 4, Additional file 1: Tables S3–4).
In the TIM-1, the virulence gene expression profiles
were more induced in gastric effluents and repressed in
ileal effluents, particularly from 120min digestion
(Fig. 4a). Two distinct expression patterns were dis-
cerned for the enterotoxins eltB and estP in both gastric
and ileal effluents. The mean expression of estP
Fig. 2 Dynamics of ETEC survival in different gastrointestinal regions of the TIM-1 and M-SHIME systems. a After introduction of a glass of ETEC-
contaminated water in the TIM-1 stomach, the number of cultivable ETEC cells in each compartment was determined by plate counts. Results are
expressed as mean concentrations in log10 CFU mL
−1 ± SD of four independent replicates (red line), compared with an inert and non-absorbable
transit marker indicating 100% survival (gray dashed line). Bacterial curves below that of the transit marker reflect cell mortality, while curves
above the transit marker are indicative of bacterial growth. The level of pH in each compartment is illustrated in green. No statistical significant
differences were found between ETEC and transit marker kinetics. b After gastro-jejunal digestion of a glass of ETEC-contaminated water under
static batch, the pre-digested ETEC inoculum was introduced in the M-SHIME ileum at day 13 and followed up till 122 h post-infection in the
luminal and mucosal phases of the ileum and ascending colon. ETEC survival was estimated by qPCR and expressed in log10 gspD copy number
mL−1 ± SD of six different healthy donors. Statistically significant differences between ETEC survival in the luminal vs the mucosal phases are
denoted at p < 0.05 (*), as determined by pairwise Wilcoxon rank sum tests with Holm correction
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significantly increased by 2.2 ± 1.0 log2 fold (p = 0.03)
upon exposure to gastric conditions in the first 10 min
(pH 3.2), while eltB expression was unchanged, as deter-
mined by the Friedman post hoc Nemenyi test. Then,
from 20 to 60min digestion, eltB tended to be repressed
and positively correlated with low pH (Additional file 1:
Fig. S3A) while estP expression was unchanged com-
pared with T0 (Fig. 4a). In the ileal effluents, eltB tended
to be induced in half of the replicates in the first 180min
of the digestion. estP was repressed from T120 to
T300 min in the ileal effluents, with a significant − 7 ±
0.6 log2 fold repression at T240 min (p = 0.05). The two
genes estP and cfa/Ib displayed similar expression profiles
in ileal effluents (Fig. 4a, Additional file 1: Fig. S3B). Then,
leoA and tolC were expressed at a low level in gastric efflu-
ents and tended to be under-expressed in ileal effluents.
The fimH gene encoding for type 1 pili was slightly over-
expressed in gastric effluents at T20, as for tia (Fig. 4a). Sur-
prisingly, rpoS which is known to be activated in response
to environmental stresses was not over-expressed at low
pH in the stomach.
The same set of ETEC virulence genes (except rpoS)
was analyzed in the ileum and ascending colon lumen of
six distinct donors (Fig. 4b). In comparison with the T0,
the virulence genes were significantly (p = 0.01) under-
expressed at late time points of fermentation in both gut
regions (T27 and 29 h post-infection). The enterotoxin
encoding genes eltB and estP displayed a somewhat
Fig. 3 Dynamics of ETEC membrane integrity determined by PMA-qPCR in the TIM-1 and M-SHIME. ETEC membrane integrity was estimated by
PMA-qPCR (Enterobacteriaceae 16S rRNA and ETEC gspD genes for TIM-1 and M-SHIME samples, respectively) and expressed as the average
percentage of intact (green) and damaged (shade of pink) ETEC cells. Damaged ETEC cells were obtained after deducting the number of intact
cells from the total ETEC cells measured by qPCR. ETEC membrane integrity was determined over time: a in the inoculum, gastric and ileal
effluents of the TIM-1 (n = 4) and b in the inoculum, ileum, and ascending colon of the M-SHIME (n = 6). When inter-individual variability was
important, a second doughnut was represented
Roussel et al. BMC Biology          (2020) 18:141 Page 6 of 21
similar expression profile but with donor-dependent differ-
ences. eltB was significantly over-expressed 5 h post-
infection in the colon in five donors with a 2- to 3-fold log2
induction in donors 2, 3, 4, and 6 and a 7-log2 fold induc-
tion in donor 5. In the ascending colon, leoA was predom-
inantly repressed over time. tolC expression did not
substantially change compared to T0, especially in the
ileum. In contrast, tia expression was consistently repressed
in the ascending colon (Fig. 4b). cfa/Ib mRNA was not
amplified either in the ileum and colon. Finally, correlations
between genes were mostly found in the ileum compared
to the ascending colon (Additional file 1: Fig. S3C, D).
LT production is undetected in the stomach and maximized
in ascending colon despite high donor variability
At the protein level, LT enterotoxin production was
quantified in the TIM-1 and M-SHIME (Fig. 5). LT was
absent from the gastric effluents, while the toxin was de-
tected in the ileal effluents (Fig. 5a). LT production was
maximal and significantly increased compared with T0
after T120 min digestion, with a mean of production of
185 ± 72 pgmL−1 (p = 0.014), as determined by the
Friedman post hoc Nemenyi test. No toxin was mea-
sured in the SHIME ileum during the first 3 h post-
infection in all donors (Fig. 5b); yet, LT was produced at
high levels varying between 3500 to 7200 pgmL−1 in the
ascending colon, 5 h post-infection in three (donors 1, 2,
and 3) out of the six donors (p = 0.042). Although lower,
LT production was still achieved 20 h post-infection in
the ileum, by three (donors 1, 2, and 3) of the six donors
(Fig. 5b). Remarkably, the donors displaying the high-
est estP gene expression level (donors 1 to 3) in the
ascending colon (Fig. 4b) also produced the highest
amount of the LT toxin (Fig. 5b). LT toxin produc-
tion was found to be negatively correlated with ETEC
survival at the end of digestion in the ileum of the
TIM-1 and M-SHIME (Additional file 1: Fig. S3B, C).
Microbes define the regional identity of the gut
compartments
The microbial populations in the different simulated en-
vironments of the M-SHIME were separately derived
from the fecal microbiota of six donors. The experimen-
tal set-up allowed to discriminate between cross-
sectional and longitudinal regions: ileum lumen, ileum
mucus, ascending colon lumen, and ascending colon
mucus (Fig. 6, Additional file 1: Fig. S4–6). The gut
regionalization resulted in profound differences in
microbiota composition, relative abundance, and Simp-
son α-diversity (Additional file 1: Fig. S7). At family and/
or genus level, the ileum lumen was characterized by a
high relative abundance of Enterobacteriaceae and
Fig. 4 Dynamics of ETEC virulence gene expression in different gastrointestinal regions of the a TIM-1 and b M-SHIME. Results were determined
by RT-qPCR, expressed and colored according to the log2 fold-change. For reasonable statements, statistically significant differential expression
had to meet two criteria: a mean log2 fold change expression of ≥ 1 (induction denoted in shade of green) or ≤ − 1 (repression denoted in
shade of red) and a p ≤ 0.05. The statistically significant differences in average of log2 gene expression at each time points for the four (TIM-1) or
six (M-SHIME) replicates were compared to the initial inoculum (T0) and marked by the white frames in the heatmap, as determined by the
Friedman post hoc Nemenyi test
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Klebsiella, while donors 4 and 6 displayed a higher abun-
dance of Anaerovibrio (Fig. 6a). In contrast, the ascending
colon lumen was dominated by Bacteroides, Faecalibacter-
ium, Lachnoclostridium, and Prevotella in most of the do-
nors, except for donors 4 and 6 who displayed a high
abundance of Succinivibrio genus (Fig. 6a). Species be-
longing to Firmicutes prevail in the mucosal niche (Fig. 6b,
Additional file 1: Fig. S5). The ileum mucus was character-
ized by a high relative abundance of Anaerovibrio, Klebsi-
ella, and Mitsuokella while increased microbe diversity
was found in the ascending colon (Fig. 6b).
Unique ETEC challenge modulates gut microbiota
depending on the niche specificity
Distance-based redundancy analysis (db-RDA), a robust
method for testing group dissimilarities, confirmed that
“gut region” (e.g., ileum lumen, ileum mucus, ascending
colon lumen, ascending colon mucus) was the predominant
explanatory variable for dissimilarities in microbiota com-
position (19.5%, p = 0.001) (Additional file 1: Fig. S8A). The
factor “donor” was the second most important contributor
(6.5%, p = 0.001) (Additional file 1: Fig. S8B). Although a
marked decrease of the Simpson α-diversity index was dis-
played in ileum lumen and mucus following ETEC infec-
tion (Additional file 1: Fig. S7), the factor “period” assessing
the effect of pre- and post-infection did not profoundly shift
the overall microbiota composition (0.9%, p = 0.53) (Add-
itional file 1: Fig. S8C). To get rid of the total gut region
dissimilarity and better evaluate the impact of ETEC chal-
lenge, the evolution of the microbial community compos-
ition preceding (days 7–12) and following ETEC infection
(days 13–20) was assessed by discriminating the four gut
regions (Additional file 1: Fig. S9). ETEC significantly con-
tributed to the variation of the microbial community
structure in the ileum mucus (2.6%, p = 0.01) and ascend-
ing colon lumen (1.6%, p = 0.04).
We further investigated the significant changes in
microbiota abundance between pre- and post-infection
periods in the different gut regions through a differential
analysis of count data (DESeq2) (Fig. 7). Mostly, species
belonging to Firmicutes were shifted following the ETEC
challenge. In both the ileum and ascending colon, Clos-
tridium butyricum (OTU18) was decreased while Bacil-
lus xiaoxiensis (OTU275) as well as Clostridium scindens
(OTU90) were stimulated in the ascending colon only
(Fig. 7b, c). A few OTUs belonging to the Proteobacteria
were decreased in the ileum and ascending colon such
as OTU4 (Enterobacter genus), OTU19 (Citrobacter
genus), and Klebsiella variicola (OTU115) except in the
ileum mucus where an upsurge was observed. Mycobac-
terium (OTU201) was also remarkably increased in the
ileum mucus upon ETEC supplementation. Finally, two
OTUs belonging to Bacteroidetes, OTU40 (Prevotella
genus), and OTU156 (Muribaculaceae family) were
stimulated in the ascending colon following the ETEC
challenge (Fig. 7b–d).
Propionate concentration is increased following the ETEC
challenge in the ileum and ascending colon
The observed changes in microbial community compos-
ition between the ileum and ascending colon are also in-
dicative of a significant change in its metabolic activity.
Fig. 5 Dynamics of LT toxin production in different gastrointestinal regions of the TIM-1 and M-SHIME. Results were determined by GM1 ELISA.
LT toxin production was expressed as mean pg mL−1 ± SD of a four independent replicates in the gastric and ileal effluents of the TIM-1 and b
six different donors (denoted by the different shapes) in the luminal ileum and ascending colon of the M-SHIME. The horizontal black dashed line
represents the detection limit. Statistically significant differences in LT toxin production over time compared to the initial inoculum (T0) are
denoted at p < 0.05 (*), as determined by the Friedman post hoc Nemenyi test
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Low SCFA concentrations were observed in the ileum
compared to the ascending colon (Additional file 1: Fig.
S10). ETEC infection had an impact on fermentation ac-
tivity in both gut regions. A significant increase of the
average propionate ratio was observed in both gut re-
gions (ileum p = 0.007; ascending colon p = 0.01), while
a decrease of the average acetate ratio (p = 0.01) only
occurred in the ileum, as determined by pairwise Wil-
coxon rank sum tests with Holm correction (Fig. 8a, Add-
itional file 1: Fig. S10). The infection displayed a
pronounced change in SCFA concentrations in the as-
cending colon, especially a significant increase of propion-
ate for donors 2, 4, and 5 (p = 0.01) up to 5.6 mM
(Fig. 8b). In contrast, acetate tended to decrease and
Fig. 6 Genus level microbial community composition of the ileum and ascending colon environments in the M-SHIME. The area graphs show the
relative abundance of the 15 most abundant genera in the a luminal and b mucosal ileum and ascending colon from six different donors over
the course of 20 days fermentation, as determined by amplicon sequencing. ETEC infection is demarcated by the dashed line at day 13
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Fig. 7 (See legend on next page.)
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butyrate concentration significantly decreased (p = 0.04)
especially for donors 1, 5, and 6 (Fig. 8b). No change in
branched short fatty acid concentration was seen. Next,
we examined the existing correlations between SCFA con-
centrations and ETEC survival and virulence (Add-
itional file 1: Fig. S11). No significant correlations were
found in the ileum. In the ascending colon, acetate and
propionate displayed significant and negative correlations
with LT toxin production and estP gene expression (en-
coding for the ST toxin), while butyrate was positively cor-
related with LT production (Additional file 1: Fig. S11).
Discussion
Interactions between ETEC bacteria, physicochemical
factors, and microbiota in the human gastrointestinal
tract are scarcely understood due to multiple, successive,
and complex ecosystems crossed by the pathogen. With
the use of validated and complementary in vitro models of
the human digestive environment, TIM-1, and M-SHIME,
the key objectives of the study were to unravel the dynam-
ics of ETEC H10407 survival and virulence throughout
the simulated human gastrointestinal tract from the stom-
ach to the ascending colon. Interplay with gut microbial
community and activity was also assessed in the different
gut niches, i.e., ileum/ascending colon, and microenviron-
ments, i.e., lumen/mucus. This study represents the most
complete survey of ETEC pathogenesis in the mimicked
human gastrointestinal ecosystem (Fig. 9).
Low gastric pH is the first challenge a pathogen faces
upon ingestion. The antimicrobial effect from gastric di-
gestion is often overestimated when static in vitro
models with constant low pH are used. For instance,
Masters et al. found ETEC cells to be undetectable upon
2 h static exposure at pH 2 [18]: this is not representative
of healthy adult in vivo conditions. The TIM-1 model
from the present study accurately captures the gradual
pH drop and gastric emptying into the duodenum,
resulting in ETEC being exposed to a low pH for a short
time at the end of gastric digestion. Lower ETEC plate
counts were hence only observed after 45 min of gastric
digestion when pH dropped below 2. This drop in ETEC
culturability only reveals one aspect of ETEC viability:
we therefore investigated ETEC physiological states by
PMA-qPCR and flow cytometry. Strikingly, we observed a
sudden change of ETEC membrane integrity upon short
exposure to low pH. This resulted in a high number of
ETEC cells with partially compromised membranes that
we assume to be related to a viable but non-culturable
state [19]. This intermediate viability state temporarily
prevents ETEC from growing; yet, we assume that this is a
reversible effect and that most of the altered cells are re-
suscitated by physicochemical stimulus during passage in
lower intestinal sections, as described here-after. To date,
there is no effective method to distinguish culturable cells
from resuscitation cells [20].
ETEC is then subjected to the duodenal conditions. The
initially high levels of bile salts, an antimicrobial compound,
in TIM-1’s simulated duodenum resulted in a progressive
decrease of ETEC survival until halfway duodenal digestion
[21]. Simulated reabsorption of bile salts and further pH in-
crease as intestinal digestion progresses contributed to
ETEC‘s increased survival in the jejunal and ileal compart-
ments. Altogether, the number of viable ETEC was partially
restored at the end of the 5-h gastrointestinal digestion with
a final survival of 65% (percentage of culturable cells com-
pared to the initial ETEC inoculum) in TIM-1 pooled ileal
effluents and gastrointestinal residues.
The ileum is known to be the prime site of ETEC patho-
genesis [4]. We therefore added another unique feature to
this study by using an ileal M-SHIME to study ETEC’s
colonization ability in the ileal environment in the pres-
ence of ileal microbiota and under anaerobiosis. Interest-
ingly, both luminal and mucosal microenvironments
maintained above 6 log10 mL
−1 of ETEC up to 5 days
post-infection. Intriguingly, ETEC survival in the ileal mu-
cosa was higher than the ileal lumen. The mucus layer
forms a natural habitat of intestinal symbionts and can
serve as a nutrient-rich environment facilitating growth of
both endosymbionts as pathogens. These observations
complement our previous study where ETEC was also
found to attach to mucin proteins yet in absence of micro-
biota [22]. While the nutritional role of the mucus layer
for ETEC is unknown, it is noteworthy that ETEC’s muco-
sal adhesion efficacy was higher (51%) than that of the ad-
herent invasive E. coli (AIEC) pathotype (20%) [23].
ETEC then transits to the colonic part. The colon is
devoid of oxygen and displays a long residence time,
which enhances the growth of anaerobic bacteria (10–
11 log10 mL
−1). It results in a high metabolic activity
through the fermentation of partially digested/un-
digested food particles [24, 25]. Similar to our findings
in the ileal environment, ETEC was able to persist and
(See figure on previous page.)
Fig. 7 Log2 fold change of normalized microbial abundances between the pre- and post-infection phases in the M-SHIME. Positive log2 fold
change indicates a stimulation of the a genera and c species in the post-infection period (in green) compared to a negative log2 fold change
which indicates a reduction of the genera/species in the post-infection period (in red). The log-transformed adjusted p value is displayed on the
y-axis and the α = 0.05 significance level is indicated by a dashed line. The volcano plots do not discriminate the gut regions. Significant
differences in b genus and d OTU level abundance between pre- and post-infection period. The abundance is displayed for the different gut
regions. Colored labels indicate the phylum classification of the respective genera and species
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Fig. 8 SCFA ratios and concentrations in the ileum and ascending colon compartments over time in the M-SHIME. SCFA
concentrations displaying stability from day 7 to 12 were retained as the pre-infection period, and from day 13 to 20 as the post-
infection period. a SCFA ratio was calculated as the mean acetate, propionate, and butyrate ratios of 6 donors ± SD. Statistically
significant differences between pre- and post-infection periods are denoted at p < 0.05 (*) and p < 0.01 (**) as determined by pairwise
Wilcoxon rank sum tests with Holm correction. b Difference in average concentrations of SCFA (mM) between pre- and post-infection
periods in the ileum and ascending colon for the six donors. Following ETEC infection, a decrease of SCFA concentration is displayed
in shade of blue while an increase is in shade of red. Statistically significant differences between pre- and post-infection periods are
denoted at p < 0.05 (*) and p < 0.01 (**) as determined by pairwise Wilcoxon rank sum tests with Holm correction
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even gain a growth advantage over the luminal and mu-
cosal colonic microbiota. Altogether, our TIM-1 and M-
SHIME research demonstrated ETEC’s robustness across
the entire digestive tract, even in the presence of repre-
sentative physicochemical and enzymatic conditions and
gut microbial populations.
The potency of ETEC to infect its host depends on
virulence gene expression which is in turn determined
by many gastrointestinal cues. So far, ETEC gene
regulation has never been investigated in detail under
realistic human upper and lower gastrointestinal con-
ditions. We profiled not less than seven virulence genes
encoding for enterotoxins (eltB and estP), enterotoxin re-
lease (leoA and tolC), adhesins (cfa/Ib, tia, fimH), stress re-
sponse (rpoS) genes, and the actual enterotoxin LT
production. We found most of the virulence genes to be
switched on in the stomach and switched off in the TIM-1
ileal effluents, at late post-infectious stage in the M-
SHIME ileum and in the ascending colon.
We followed the rpoS gene expression specifically in the
TIM-1. This general stress-response regulator in E. coli is
known to contribute to the bacterial survival, for example,
under acidic pH conditions. Over time, we found that the
rpoS gene was basally expressed upon gastric digestion
while under-expressed in the ileal effluents. At this stage,
it remains difficult to correlate the gene expression pattern
with the observed ETEC survival. In fact, most of the acid
resistance system requires extracellular metabolites (e.g.,
glutamate, lysine) to be inducible, as well as for rpoS
which requires polyamines [26]. In the TIM-1 stomach,
the operation of such systems for ETEC was not possible
due to the absence of these amino acids as only a glass of
water was introduced into the system. It would be there-
fore of high interest to use a complex food matrix for
ETEC vehicle that provides such metabolites to re-
examine the regulation of rpoS during gastric digestion.
Upon gastric digestion, the gene eltB encoding LT
toxin production was repressed at a pH below 3.6 and
no production of LT toxin was observed. This pH-
dependency for eltB and LT protein observed in our
complex gastric in vitro system confirms previous re-
ports from in vitro batch and in vivo (mouse) studies
[27–30]. Interestingly, in the TIM-1 ileal effluents as
well as in the M-SHIME ileum, no correlation was found
between LT toxin production and eltB gene expression.
On top of that, the eltB post-transcriptional regulations
are key determinants in LT toxin production [28], and
we also assumed that due to the digestive transit, toxins
produced in an upper compartment can simply be found
in a lower compartment without any production at this
site (e.g., ileum vs ascending colon). The LT toxin can
be associated with the lipopolysaccharide of the outer
membrane of ETEC cells [30]: we therefore thought that
the LT toxin can be released upon ETEC cell lysis,
Fig. 9 Biogeography of ETEC H10407 pathogenesis in the human in vitro systems TIM-1 and M-SHIME. The main results of the study are summed
up from the stomach to the ascending colon. For each digestive compartment, the main physicochemical and/or biotic factors reproduced are
indicated on the top of the circle
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explaining the high production of the LT 20 h post-
infection when ETEC survival decreases. However, the
ETEC cell lysis observed in the stomach does not con-
firm this assumption, probably due to low pH. Our re-
sults also demonstrated that the LT toxin can be
produced both under aerobic or anaerobic conditions, as
previously shown in static cultures [31]. In comparison
with eltB, we found that estP encoding for ST toxin does
not follow the same expression profiles in both TIM-1
and M-SHIME. That result could be related to distin-
guishable gene regulation patterns. For instance, it is
known that the CRP regulator represses eltAB transcrip-
tion while it positively regulates estP expression [32].
We then followed up leoA and tolC encoding for the
proteins contributing to secretion and delivery of entero-
toxins. No significant induction of both genes was ob-
served in the TIM-1 but leoA was repressed all along the
M-SHIME anaerobic compartments and tolC had a ten-
dency to be over-expressed in a donor-dependent man-
ner. These results suggest that changes in environmental
oxygen (TIM-1 vs M-SHIME) greatly influence the viru-
lence factor expression in ETEC, as shown in a recent
study comparing the levels of oxygen in batch cultures
and stool samples [33]. The genes encoding for the
adhesins CFA/Ib, tia, and FimH [6] have also been so far
scarcely investigated. Here, we show for the first time
that fimH and tia tended to be over-expressed after 20
min in the stomach, when pH is under 4. Although the
underlying mechanisms are unknown, the upregulation
of many fimbrial and adhesin-related genes has been re-
ported after acidic exposure in another E. coli pathotype,
enterohemorrhagic E. coli (EHEC) [12, 33]. In contrast,
fimH and tia were repressed in TIM-1 and M-SHIME
ileum (aerobic without microbiota vs anaerobic with
microbiota), as well as in the ascending colon. This indi-
cates the lack of direct roles of oxygen and microbial
bulk in the modulation of fimH and tia gene expression.
It therefore suggests that at the vicinity of luminal con-
tent, the presence of polarized cultured intestinal epithe-
lium, producing apical brush borders with defined
microvilli similar to intestinal human enterocyte could
be required for adhesin genes induction [34]. Then, it is
noteworthy that FimH acts in concert with CFA/I for
optimal adhesion, as observed under in vitro Caco-2
cells assay [35]. In our study, we did not find a correl-
ation between both gene expression patterns. cfa/Ib gene
displayed a basal expression in the gastric environment
and a repression in the TIM-1 ileum. A significant posi-
tive correlation was found between cfa/Ib and estP ex-
pression profiles (p < 0.05, Spearman’s rank correlation),
although the two genes are carried by different plasmids,
i.e., p948 and p666, respectively. Surprisingly, the ampli-
fication of cfa/Ib failed under experimental conditions of
the M-SHIME. It is unlikely that the presence of gut
microbiota has created a rearrangement or mutation
within the existing cfa/Ib gene since cfaD (encoding for
another subunit of CFA/I adhesin, in the same operon
than cfa/Ib) was successfully amplified and under-
expressed in presence of microbiota in anaerobic stool
samples [31].
Concurrently to the abiotic factors found in the hu-
man gastrointestinal tract, ETEC faces and competes
with successive microbial populations for nutrients and
space [36]. Here, we examined the effect of a single ad-
ministration of ETEC (~ 10 log10) on the microbial com-
munity composition and activity in the M-SHIME. It is
the first time that such modulation was followed
spatially in distinct microbial gut longitudinal regions,
i.e., ileum/ascending colon, and cross-sectional microen-
vironments, i.e. lumen/mucus, and this separates for six
human-derived microbiota. We found the ileum and as-
cending colon to be successfully reproduced in the M-
SHIME in terms of community composition, diversity,
and metabolic activity [37]. Interestingly, M-SHIME was
able to maintain an individual’s unique microbiota pro-
file as donor origin was a major explanatory variable for
dissimilarities in microbiota composition, together with
the gut region.
Mimicking ETEC infection in M-SHIME did not result
in profound shifts in the microbiome. Yet, correlations
between ETEC presence and separate microbial genera
from the mucosal ileum mucus and luminal colon were
observed. Key changes were mostly found in the Firmi-
cutes phylum with a decrease in Clostridium butyricum,
a potentially health-promoting microbe [38]. Conversely,
Clostridium scindens a species capable of converting pri-
mary bile acids to toxic secondary bile acids was stimu-
lated [39]. The mucosal ileum showed blooms of taxa
recognized as opportunistic pathogens: Klebsiella varii-
cola, recently involved in bloodstream infections, and
non-tuberculous Mycobacterium [40, 41]. Opportunistic
pathogens are often associated with stress conditions for
the host [42]. However, we demonstrated that the prolif-
eration of opportunistic pathogens is a host-independent
effect, related in this case to ETEC infection. Although
limited and highly gut region-specific, the ecological fea-
tures that we observed following ETEC infection may re-
flect an imbalance in the microbiota. A previous clinical
study suggested that the increase of Firmicutes:Bacteroi-
detes ratios in human fecal samples 72 h post-ETEC in-
fection resulted in a dysbiotic microbiota, even though a
significant difference in the microbial diversity was not
observed when comparing ETEC-free travelers to ETEC-
infected travelers [9]. In our work, we did not find a sig-
nificant change in bacteria diversity, which is in line with
two other studies performed on fecal samples of ETEC-
positive Bangladeshi patients or experimentally infected
adults [10, 11].
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Reflecting the microbial metabolic activity, SCFA are
important determinants of interactions between the
microbiota and enteric pathogens. For instance, SCFA
can regulate the expression of virulence genes in EHEC
and Salmonella typhimurium [42–44]. In our study,
SCFA concentrations in the ileum and ascending colon
displayed significant changes following ETEC infection
mainly through the increase of the propionate concen-
tration (ileum p = 0.007; ascending colon p = 0.01, pair-
wise Wilcoxon rank sum test with Holm correction).
Propionate is acknowledged to be a health-promoting
microbial metabolite, but direct interaction between
ETEC and propionate has not yet been documented.
Conclusions
To conclude, ETEC pathogenesis in the human gastro-
intestinal tract was thus far considered a “black box.”
Our present study provided for the first time a detailed
insight into the temporal and spatial modulation of
ETEC H10407 survival, virulence, and its interactions
with gut microbes by combining the two most complete
and well-validated TIM-1 and M-SHIME systems world-
wide. Future results will enable prospecting of preventive
and/or therapeutic strategies.
Methods
ETEC strain and growth conditions
The prototypical ETEC strain H10407 serotype O78:
H11:K80 (LT+, ST+, CFA/I+) isolated from a Bangladeshi
patient with cholera-like syndromes was used in this
study [45]. Bacteria were routinely grown under agita-
tion (37 °C, 125 rpm, overnight) in Luria Bertani (LB)
broth (BD Difco) until OD600nm = 0.6 (stationary phase),
to achieve a final amount of 10 log10 CFU in the TIM-1
inoculum.
Inoculation and operation of the TIM-1
The experimental set-up of the TIM-1 was previously
described [19]. Based on in vivo data, the TIM-1 system
was programmed to simulate the physicochemical di-
gestive conditions encountered in a healthy adult when a
glass of water (main route of transmission for ETEC) is
ingested (Additional file 1: Table S5) [12]. The bacterial
suspension (200mL) introduced into the TIM-1 system
consists of mineral water experimentally contaminated
with ETEC at a final amount of 10 log10 CFU. Two types
of experiments were performed: gastric digestions (total
duration of 60 min) and gastrointestinal digestions using
the entire TIM-1 model (total duration of 300min). Di-
gestions were run in quadruplicate (Fig. 1a).
TIM-1 sampling
The initial bacterial suspension (T0) was collected and
samples were regularly taken during in vitro digestions
from each digestive compartment (stomach, duodenum,
jejunum, and ileum) (Fig. 1a). Gastric and ileal effluents
were also collected on ice and pooled on 0–10, 10–20,
20–40, and 40–60min for gastric digestions and hour-
by-hour during 5 h for gastrointestinal digestions. Time
75min represents the fraction remaining at the end of
gastric digestions in the stomach and T 330min the gas-
tric and small intestinal residues at the end of gastro-
intestinal digestions. Samples collected for plating and
flow cytometry were immediately treated. The number
of cultivable ETEC in each digestive compartment of the
TIM-1 was determined by direct plating onto LB agar
(overnight incubation at 37 °C) [19]. Samples used for
DNA or RNA extraction were centrifuged (6339×g, 10
min, 4 °C). DNA samples were stored at − 20 °C while
RNA were resuspended in 500 μL RNAlater® (Thermo
Fisher Scientific) prior to storage at − 80 °C. The super-
natant was stored at − 20 °C for an enterotoxin ELISA
assay.
M-SHIME experimental set-up
The M-SHIME® consists of a series of connected double-
jacketed reactors (Pierreglas, Vilvoorde, Belgium). Based
on in vivo data, the system reproduces the conditions of
the upper and lower part of the human gastrointestinal
tract, operated in a semi-continuous mode to mimic
gastrointestinal transit [14, 46]. Three successive compart-
ments simulating the stomach/combined duodenum-
jejunum, the ileum, and the ascending colon were used in
the set-up (Fig. 1b). The mucosal environment was
reproduced in both the ileum and ascending colon com-
partments, incorporating microcosms (AnoxKaldnes K1
carrier, AnoxKaldnes AB) coated with type III porcine
mucin-agar (Sigma-aldrich), as described by Van den
Abbeele et al. [47].
Inoculation and operation of the M-SHIME
Fresh fecal samples were collected from six healthy
adults (3 women and 3 men aged from 25 to 36 years
old) (Additional file 1: Table S6) in sterile airtight con-
tainers comprising an Anaerocult® A strip (Merck) to
maintain anoxic conditions until processing. A 20% (w/
v) fecal slurry was prepared as described by De Boever
et al. [46] and inoculated in separate ascending colon
vessels pre-filled with 500 mL nutritional medium (Pro-
digest, Zwijnaarde, Belgium) in order to obtain a final
concentration of 1% (w/v) fecal material [46, 47]. All ves-
sels were flushed with N2 immediately after inoculation
to generate anaerobic conditions. After the initial over-
night incubation of the fecal sample in the ascending
colon, a semi-continuous feeding pattern with nutri-
tional SHIME medium, simulated gastric, biliary, and
pancreatic secretions was established (Additional file 1:
Table S5) by pumping feed into the stomach/combined
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duodenum-jejunum vessel three times a day. Subse-
quently, this mixture was transferred to the ileum ves-
sels, followed by the ascending colon vessels. After a
transit time of 3 h in the ileum and a hydraulic residence
time of 20 h in the ascending colon, the entering volume
was discharged. In order to establish an ileal microbial
community at low biomass concentration, a 100-μL
feedback inoculation from the ascending colon vessels
towards the respective ileum vessels was conducted on
days 3 and 8. From day 3 onwards, the nutritional
SHIME medium was supplemented with simple sugars
0.5 g L−1 each, i.e., glucose, fructose, galactose, maltose,
and sucrose to enhance the growth of bacteria usually
found in the small intestine. To mimic the lower turn-
over rate of the mucus environment and avoid wash-out
of mucus adherent bacteria, half of the mucus beads
were replaced every 2–3 days in each of the ileum and
ascending colon vessels [48].
The six fecal donors were evaluated in two M-SHIME
runs, each involving three individuals over the course of
20 days. A stabilization period (adaptation to the in vitro
conditions) of 7 days was applied. After a pre-infection
period from day 7 to 12, the system was challenged at
day 13 in the SHIME ileum vessels with ETEC by in-
oculation of 10 log10 CFU, followed by a post-
infectious period from day 14 to 20. Prior to the
challenge, ETEC was pre-digested 2 h 30 under static
conditions, to reproduce the gastro-jejunal digestion
of a glass of contaminated mineral water, where phys-
icochemical conditions were close to those found in
TIM-1 (without nutritional medium, under aerobic
conditions) (Additional file 1: Table S7). Low variabil-
ity in microbiota between technical replicates from
the same donor has been tested on a separate SHIME
experiment (Additional file 1: Fig. S12).
M-SHIME sampling
SHIME suspensions from the ileum and ascending colon
vessels were sampled daily for short-chain fatty acid
(SCFA) analysis. Samples were also regularly collected
for DNA and RNA extractions and ELISA measurement
and stored as previously explained for TIM-1 samples.
Mucus samples were obtained every 2–3 days [48]. Two
hundred fifty milligrams of mucus was aliquoted and
stored at − 20 °C before DNA extraction.
DNA extraction
Total DNA from the TIM-1 and M-SHIME experiments
was extracted according to Geirnaert et al. [48]. The
DNA samples were stored at − 20 °C and the quality was
analyzed by gel electrophoresis (1.2% (w/v) agarose) (Life
technologies). The DNA samples were diluted 1:10 in
1X TE buffer (Tris and EDTA) for further ETEC
quantification.
qPCR and PMA-qPCR-based quantification
Digestive samples from TIM-1 and M-SHIME were
collected in duplicate and stained or not with 50 μM
PMA (Interchim). The qPCR procedure was per-
formed using the StepOnePlus Real-Time PCR sys-
tem (Applied Biosystems). The total reaction volume
of 10 μL contained 5 μL of Takyon Low Rox Sybr
Master Mix dTTP blue (Eurogentec), 0.45 μL
(10 μM) of 16S of Enterobacteriaceae primers for
TIM-1 and gspD primers for M-SHIME (Add-
itional file 1: Table S8) [49, 50], 3.1 μL of nuclease-
free water (Sigma-Aldrich), and 1 μL of template
DNA. The non-template control consisted of 1 μL
nuclease-free water. Each reaction was performed in
triplicate in a sealed 96-well plate. The qPCR ther-
mal cycling amplification procedure followed was
previously described [19]. The melting curves of
PCR amplicons were checked to ensure primer spe-
cificity and yielded a single melting peak.
ETEC pure cultures (OD600nm = 0.3, exponential
phase, LB broth) stained or not with PMA were used
as DNA templates. Standard curves were thus gener-
ated by PCR amplification of the 16S Enterobacteria-
ceae rRNA and ETEC gspD genes for TIM-1 and M-
SHIME samples, respectively [19]. Tenfold serial dilu-
tions of the standard were prepared in TE buffer and
stored at − 20 °C until further use. As a negative con-
trol, an ETEC pure culture was subjected to lethal
heat-treatment (95 °C, 15 min) and stained or not with
PMA. The absence of viable ETEC in the heat-treated
samples was confirmed on LB agar plates.
Flow cytometry analysis—Live/Dead ETEC quantification
Adequate volumes of gastric or ileal effluents (Live/Dead
and membrane potential kits) from TIM-1 were centri-
fuged (9000×g, 5 min, 20 °C). Pellets were resuspended
into PBS at pH 7.3 to obtain approximately 6 log10
cells mL−1. Flow cytometry analysis was performed on a
CyFlow SL cytometer and data were collected with Flow-
Max software version 2.3 (Partec) [19]. Bacteria were
double-stained using the Live/Dead BacLight™ Kit
(L34856 Molecular Probes) according to the protocol
previously described [19].
RNA isolation, DNAse treatment, and quality control
Total RNA was extracted from TIM-1 and SHIME di-
gestive samples using the TRIzol® method (Invitrogen)
[51]. RNA pellets were resuspended in Diethyl Pyrocar-
bonate (DEPC)-treated water (Invitrogen) and stored at
− 80 °C. DNAse treatment with the TURBO DNA-free™
Kit (Invitrogen) was performed to remove any contamin-
ating genomic DNA according to the manufacturer’s
recommendations. The efficiency of DNAse treatment
was checked by PCR [18] using eltB gene-specific
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primers (Additional file 1: Table S8) [52]. The lack of
amplification was indicative of the successful DNA re-
moving from RNA samples. PCR products were analyzed
by gel electrophoresis (1.2% (w/v) agarose). RNA was
quantified using the NanoDrop ND-1000 (Thermo
Fisher Scientific). A minimal concentration of 10 ng μL−1
was required to carry out the reverse transcription poly-
merase chain reaction (RT-PCR). RNA integrity was
checked using the 2100 Bioanalyzer and the RNA 6000
Nano kit (Agilent Technologies) according to the manu-
facturer’s instructions. Only high-quality RNA was
retained for subsequent transcriptional analysis.
Quantitative reverse transcription (RT-qPCR)
RNA was reverse transcribed into complementary DNA
(cDNA) by using the PrimeScript™ RT Reagent Kit
(TAKARA Bio Inc) according to the manufacturer’s in-
structions. qPCR was performed on the cDNA. All the
primers used at a concentration of 300 nM (except tia
and leoA primers at 100 nM) are listed in Add-
itional file 1: Table S8 [49, 50, 52–58]. qPCR data were
analyzed using the comparative E−ΔΔCt method and nor-
malized with the reference genes arcA and gapA, after
controlling their stability using BestKeeper software. The
amplification efficiency of each reference gene was de-
termined by the generation of a standard curve based on
a tenfold dilution series of a set of cDNA samples from
each compartment of the TIM-1 and SHIME models.
The amplification efficiency was calculated from the
slope of the standard curves E = 10(− 1/slope); E values be-
tween 90 and 110% were considered acceptable. Differ-
ences in the relative expression levels of each virulence
gene were calculated as follows: ΔΔCt = (Cttarget gene –
Ctreference gene)at time t – (Cttarget gene – Ctreference gene)at




LT enterotoxins were measured in supernatants col-
lected from the TIM-1 and M-SHIME as previously de-
scribed [59]. Optical density was read at 450 nm using
the multiscan Tecan Infinite® 200 PRO. LT toxin con-
centrations were expressed in pg mL−1.
SCFA production
Luminal samples from the M-SHIME were diluted 1:2
with miliQ water to a total volume of 2 mL. SCFA pro-
duction was measured using capillary gas chromatog-
raphy coupled to a flame ionization detector after
diethyl ether extraction [60]. SCFA concentrations were
expressed in mM.
Statistical analysis of ETEC data
All statistical analyses were performed in R studio, ver-
sion 3.5.1. All formal hypothesis tests were conducted
on the 5% significance level (p ≤ 0.05). The assumptions
of normality and heterogeneity of variances were verified
based on visual inspection of QQ-plots and Shapiro-
Wilk (stats4_3.4.2) and Levene’s test (car_2.1-5), preced-
ing statistical hypothesis testing to assess pairwise com-
parison of (i) ETEC survival at time T in comparison
with the transit marker of the TIM-1 system, (ii) ETEC
survival at time T in comparison with the initial inocu-
lum (T0) in the M-SHIME, (iii) ETEC survival between
luminal and mucosal microenvironments at time T, (iv)
the log2 fold change in gene expression at time T in
comparison with the T0, and (v) the LT enterotoxin pro-
duction at time T in comparison with T0. The assump-
tions were not met for most variables, in which case a
non-parametric Mann-Whitney (Wilcoxon rank sum)
test with Holm correction was performed (for i, ii, iii hy-
potheses), and a Nemenyi post hoc test was conducted
following a significant Friedman test (for iv and v hy-
potheses), using the PMCMR package. Statistical hy-
pothesis testing to assess the effect of ETEC infection on
the metabolic activity (SCFA) was performed by using
the Kruskal-Wallis rank sum test, followed by pairwise
Wilcoxon rank sum tests with Holm correction for mul-
tiple testing.
Microbial community analysis
Next-generation 16S rRNA gene amplicon sequencing of
the V3-V4 region (341F-785R) was performed by LGC
Genomics (Teddington), on an Illumina MiSeq platform
using Illumina V3 chemistry (Illumina), as previously de-
scribed [60]. The sequence data have been submitted to
the NCBI (National Center for Biotechnology Informa-
tion) database under accession number PRJNA562529
[61].
Bioinformatics analysis of amplicon data
The mothur software package (v.1.40.5) and guidelines
were used to process the Illumina amplicon sequencing
data generated by LGC Genomics [62]. OTUs were de-
fined as a collection of sequences with a length between
400 and 428 nucleotides that are found to be more than
97% similar to one another in the V3–V4 region of their
16S rRNA gene after OptiClust clustering [63–66]. Tax-
onomy was assigned using the RDP database [67, 68].
The shared file, containing the number of reads ob-
served for each OTU in each sample, was loaded into R
version 3.5.1 (2018-09-04) (R Core Team, 2016). Single-
tons were removed [67]. For the most abundant OTUs,
the sequences retrieved from the 3% dissimilarity level
fasta file, obtained in mothur, were classified through
the RDP web interface using the RDP SeqMatch tool
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(restricting the search to type strains with only near-full-
length good quality sequences) and blasted in NCBI (Na-
tional Center for Biotechnology Information) against the
16S rRNA gene sequences, selecting only type material,
with optimization of the BLAST algorithm for highly
similar sequences (accession date: September 2018) [68–
70]. Although a level of uncertainty is introduced by
classification to the species level based on short 300 bp
reads, the best hit returned by both databases is used to
refer to interesting OTUs in the “Results” section of this
article. In case of inconsistencies between the RDP Seq-
Match tool and NCBI BLAST, no species-level classifica-
tion was mentioned. A more detailed overview of the RDP
Seqmatch and NCBI BLAST results for the most abun-
dant and significant OTUs (best hit as well as the next
best hits) can be found in Additional file 1: Table S9.
Statistical analysis of amplicon and metabolic data
All statistical analyses were performed in R, version 3.5.1
(2018–09-04) (R Core Team, 2016). All formal hypoth-
esis tests were conducted on the 5% significance level.
To visualize differences in microbial community com-
position between donors, period (e.g., pre- and post-
infection), and gut region (e.g., ileum lumen, ileum
mucus, ascending lumen, and ascending mucus), ordin-
ation and clustering techniques were applied. For these
purposes, the shared file was further processed to re-
move OTUs with too low abundance according to the
arbitrary cutoffs described by McMurdie and Holmes
[69]. An OTU should be observed in 5% of the samples
and read counts should exceed 0.5 times the number of
samples [69]. Rarefaction curves were constructed to as-
sure that the samples were sequenced in sufficient depth
[71]. To deal with differences in sampling depth, propor-
tional data transformed on the common scale to the
lowest number of reads was used for the purpose of
visualization [65]. Principle coordinate analysis (PCoA;
package stats4_3.3.1) [72, 73] was conducted based on
the abundance-based Jaccard dissimilarity matrix (pack-
age vegan_2.4–0) [71, 74, 75] and visualized with
ggplot2_2.1.0. This procedure was repeated on species
and genus levels focusing on the comparison between
gut regions, donor samples, and the comparison between
periods. In both gut regions, the pre-infection was de-
fined from day 7 to 12, and the post-infection from day
13 to 20. On the genus level, weighed averages of genera
abundances were a posteriori added to the ordination
plot using the wascores function in vegan [71]. To con-
firm the trends, observed data was clustered by means of
an Unweighted Pair-Grouped Method using arithmetic
Averages (UPGMA) clustering method (cluster_2.0.4)
[76]. The significance of the observed group separation
between gut region, donor, and period in the PCoA was
assessed with a Permutational Multivariate Analysis of
Variance (PERMANOVA) using distance matrixes
(package vegan_2.4–0) [71, 73]. Prior to this formal hy-
pothesis testing, the assumption of similar multivariate
dispersions was evaluated.
When comparing the effects, the influence of the gut
region, donor, and period was determined by applying a
distance-based redundancy analysis (db RDA) using the
abundance-based Jaccard distance as a response variable
(vegan) [71, 73]. The factor donor is used as a constraint
with the effect of the gut region or period being par-
tialled out. Interpretation of the results is preceded by a
permutation test of the RDA results to confirm that a
linear relationship exists between the response data and
the exploratory variables. The constrained fraction of the
variance, explained by the exploratory variables, is ad-
justed by applying Ezekiel’s formula [75].
In order to find statistically significant differences in
species abundance between the pre- and post-infection
periods, the DESeq package was applied [67, 77]. The
factors period, gut region, and donor were used in the
design formula. Statistical differences between the pre-
and post-infection were determined using a Wilcoxon
signed rank test on the proportional data. The evolution
of the microbial community structure throughout the
M-SHIME run was followed up by computing the rich-
ness (Chao 1) and Simpson diversity index on the DESeq
normalized, unfiltered data (package vegan_2.4–4).
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